Newly Found Nucleotide Could Transform Epigenetics

However, the rise of epigenetics in the past 10 years has drawn attention to a fifth nucleotide, 5-methylcytosine (5-mC), that sometimes replaces cytosine in the DNA double helix to regulate which genes are expressed. However, now there is a sixth. In recent studies, researchers revealed an additional character in the mammalian DNA code, opening an entirely new arena in epigenetic research.

The study, published online April 17, 2009, in the journal Science and conducted in Dr. Nathaniel Heintz's laboratory of molecular biology at The Rockefeller University (New York, NY,USA), suggests that a new degree of complexity exists between our basic genetic blueprints and the organisms that grow out of them. "This is another mechanism for regulation of gene expression and nuclear structure that no one has had any insight into," noted Dr. Heintz. "The results are discrete and crystalline and clear; there is no uncertainty. I think this finding will electrify the field of epigenetics."

Genes alone cannot explain the huge differences in complexity among worms, mice, monkeys, and humans, all of which have about the same amount of genetic material. Scientists have found that these differences arise in part from the dynamic regulation of gene expression rather than the genes themselves. Epigenetics, a relatively young and very hot field in biology, is the study of nongenetic factors that manage this regulation.

One key epigenetic player is DNA methylation, which targets sites where cytosine precedes guanine in the DNA code. An enzyme called DNA methyltransferase affixes a methyl group to cytosine, creating a different but stable nucleotide called 5-methylcytosine. This modification in the promoter region of a gene results in gene silencing.

Some regional DNA methylation occurs in the earliest stages of life, influencing differentiation of embryonic stem cells into the different cell types that constitute the diverse organs, tissues, and systems of the body. Recent research has shown, however, that environmental factors and experiences, such as the type of care a young rat receives from its mother, can also result in methylation patterns and corresponding behaviors that are heritable for several generations. Thousands of scientific studies have focused on the role of 5-methylcytosine in development.

The discovery of a new nucleotide may make biologists rethink their approaches to investigating DNA methylation. Paradoxically, the latest addition to the DNA vocabulary was found by chance during investigations of the level of 5-methylcytosine in the very large nuclei of Purkinje cells, according to Dr. Skirmantas Kriaucionis, a postdoctoral associate in the Heintz lab, who did the research. "We didn't go looking for this modification," he said. "We just found it."

Dr. Kriaucionis was working to compare the levels of 5-methylcytosine in two very different but connected neurons in the mouse brain--Purkinje cells, the largest brain cells, and granule cells, the most numerous and among the smallest. Together, these two types of cells coordinate motor function in the cerebellum. After developing a new method to separate the nuclei of individual cell types from one another, Dr. Kriaucionis was analyzing the epigenetic composition of the cells when he came across considerable amounts of an unexpected and anomalous nucleotide, which he labeled "x.”

The nucleotide accounted for roughly 40% of the methylated cytosine in Purkinje cells and 10% in granule neurons. He then performed a series of tests on "x,” including mass spectrometry, which determines the elemental components of molecules by breaking them down into their constituent parts, charging the particles and measuring their mass-to-charge ratio. He repeated the experiments more than 10 times and came up with the same result: x was 5-hydroxymethylcytosine, a stable nucleotide previously observed only in the simplest of life forms, bacterial viruses. A number of other tests showed that "x” could not be a byproduct of age, DNA damage during the cell-type isolation procedure or RNA contamination. "It's stable and it's abundant in the mouse and human brain," Dr. Kriaucionis commented. "It's really exciting."

What this nucleotide does is not yet clear. Initial tests suggested that it may play a role in demethylating DNA, but Drs. Kriaucionis and Heintz believe it may have a positive role in regulating gene expression as well. The reason that this nucleotide had not been seen before, the researchers report, is because of the methodologies used in most epigenetic experiments.

Typically, scientists use a procedure called bisulfite sequencing to identify the sites of DNA methylation. But this test cannot distinguish between 5-hydroxymethylcytosine and 5-methylcytosine, a shortcoming that has kept the newly discovered nucleotide hidden for years, the researchers noted. Its discovery may force investigators to review earlier work. The Human Epigenome Project, for example, is in the process of mapping all of the sites of methylation using bisulfite sequencing. "If it turns out in the future that [5-hydroxymethylcytosine and 5-methylcytosine] have different stable biological meanings, which we believe very likely, then epigenome mapping experiments will have to be repeated with the help of new tools that would distinguish the two," said Dr. Kriaucionis.

Providing further evidence for their hypothesis that 5-hydroxymethylcytosine is a serious epigenetic player, a second article to be published in Science by an independent group at Harvard University (Cambridge, MA, USA) reveals the discovery of genes that produce enzymes that specifically convert 5-methylcytosine into 5-hydroxymethylcytosine. These enzymes may work in a way analogous to DNA methyltransferase, suggesting a dynamic system for regulating gene expression through 5-hydroxymethylcytosine. Drs. Kriaucionis and Heintz did not know of the other group's work, led by Dr. Anjana Rao, until earlier in April 2009. "You look at our result, and the beautiful studies of the enzymology by Dr. Rao's group, and realize that you are at the tip of an iceberg of interesting biology and experimentation," stated Dr. Heintz, a neuroscientist whose research has not focused on epigenetics in the past. "This finding of an enzyme that can convert 5-methylcytosine to 5-hydroxymethylcytosine establishes this new epigenetic mark as a central player in the field."

Dr. Kriaucionis is now mapping the sites where 5-hydroxymethylcytosine is present in the genome, and the researchers plan to genetically modify mice to under- or over-express the newfound nucleotide in specific cell types in order to study its effects. "This is a major discovery in the field, and it is certain to be tied to neural function in a way that we can decipher," Dr. Heintz concluded.

Related Links:
Rockefeller University